Original Research

The Factors Associated with Disclosure of Intimate Partner Abuse to Clinicians

Author and Disclosure Information

 

References

Prevalence of Clinician-Patient Communication About Abuse

Summary prevalence data relating to clinician-patient communication are provided in Table 2. Among the 375 abused participants, 42% (159) reported communicating with a clinician about IPA. Among the 347 participants with a history of physical or sexual abuse, 45% (155) reported communicating with a clinician about IPA. Communication rates were significantly lower, however, among the 7% (28) of the participants who reported threats or fear of IPA in the absence of physical or sexual abuse (P <.05). Only 14% of the participants in this group reported having ever communicated with a clinician about abuse.

Overall, 28% of the participants reported direct questioning by a medical clinician about abuse; however, 85% of those who were questioned reported that they had disclosed the abuse when directly asked by their physicians. In the absence of direct questioning, only 25% of participants reported disclosing abuse to a physician. Rates of clinician inquiry about IPA did not vary significantly across ethnic groups.

There were no significant differences in frequency of communication between women reporting abuse in the past 12 months and women reporting abuse in the more distant past. Other variables not significantly associated with communication included employment, language, medical insurance status, primary care clinic, and clinician’s sex or ethnicity. In addition, having been asked directly about abuse by a clinician was not associated with age, ethnicity, birthplace, education, insurance status, or primary clinic site. However, on bivariate analysis, having been asked was significantly associated with having a regular physician (33% vs 21%, P=.02) and having been married (36% vs 23%, P=.01).

Barriers to Communication

Barriers that hindered patients’ desire to communicate included beliefs that clinicians do not ask directly about IPA and that clinicians lack time for and interest in discussing abuse. Participants were also asked whether their communication with clinicians was hindered by any of the following factors: concerns about confidentiality, fear of involving the police and courts, embarrassment, fear of shaming family, and fear that their partners would hurt or kill them.

Table 3 lists each of the perceived barriers by frequency of agreement according to participants’ abuse communication status (never communicated vs ever communicated). All of the factors (with the exception of one) were reported with greater frequency among women who had never disclosed abuse to a medical clinician than among those who had.

To determine if there were significant differences in the frequency of reported barriers according to communication status, we conducted cross-tabulations and determined statistical significance using the Pearson chi-square test. Statistical significance was defined as P less than .05. We obtained significant differences for each of the following barriers: beliefs that clinicians do not ask directly (P <.001), concerns about confidentiality (P <.001), beliefs that clinicians lack time for (P=.002) and interest in (P=.001) discussing abuse, and fear of involving the police and courts (P=.042).

Among the 108 abused Latina patients, 34% identified language barriers, and 21% reported concerns about the immigration authorities.

Predictors of Communication

To better understand the variables associated with clinician-patient communication about abuse, we used multivariate logistic regression Table 4. We found that the most significant predictor of communication was the presence of direct clinician questioning about abuse. Women who had been directly asked about abuse were much more likely to discuss it than were those who were not asked directly (OR=4.53; 95% CI, 3.20-6.40). Ethnicity also had an important effect on communication, with African American women more likely to communicate about abuse than white women (OR=1.77; 95% CI, 1.08-2.92). Immigrant status was also an important predictor. Patients born outside the United States were less likely than US-born women to have communicated about abuse (OR=0.57; 95% CI, 0.33-0.99). Also, women with concerns about confidentiality were less likely to discuss abuse with medical clinicians (OR=0.68; 95% CI, 0.48-0.94). Although age, formal education, regular clinician status, and perceptions about clinicians’ time and interest in discussing abuse had some impact on communication outcomes, none of these variables reached statistical significance.

Although each of the attitudinal barriers had an influence on the likelihood of communicating about abuse, only concerns about confidentiality reached statistical significance in the multivariate model.

Discussion

Our study is one of the first to quantitatively examine the patterns of IPA communication between an ethnically diverse group of abused women and their medical clinicians. Overall, the prevalence of IPA communication in our study (42%) was substantially higher than we had anticipated. In spite of this, most of the women (58%) had never disclosed abuse to a medical clinician. This suggests that improved efforts to identify and reduce barriers to IPA communication in the medical setting are still needed.

Pages

Recommended Reading

When should we stop mammography screening for breast cancer in elderly women?
MDedge Family Medicine
Is there any benefit to Papanicolaou (Pap) test screening in women who have had a hysterectomy for benign disease?
MDedge Family Medicine
Routine Screening for Postpartum Depression
MDedge Family Medicine
The Role of Gynecologists in Providing Primary Care to Elderly Women
MDedge Family Medicine
Should breech babies be delivered vaginally or by planned cesarean delivery?
MDedge Family Medicine
Are there adverse maternal and neonatal outcomes associated with induction of labor when there is no well-accepted indication?
MDedge Family Medicine
What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
MDedge Family Medicine
Does the increased sensitivity of the new Papanicolaou (Pap) tests improve the cost-effectiveness of screening for cervical cancer?
MDedge Family Medicine
Cesarean Delivery and Hospitals: Size Matters
MDedge Family Medicine
Differences in Institutional Cesarean Delivery Rates: The Role of Pain Management
MDedge Family Medicine